PHAnews is meant to give a picture
of recent events
and activities affecting the life of the PH community.
This compilation should not be viewed as endorsement
of the information provided or its accuracy.
For several decades researchers and
clinicians have known that patients with high blood
pressure in their lungs, a condition known as 'pulmonary
hypertension', often have diseases characterised by
inappropriate immune system activity collectively
referred to as 'autoimmunity'.
Blood cell defect linked to pulmonary hypertension
Howard Hughes Medical Institute researchers at Duke University Medical Center have found that a persistent scarcity of oxygen in body tissues – a widespread problem in patients with heart or lung disease – can create a defect of red blood cells that further exacerbates the condition by constricting blood vessels in the lung.
Pulmonary
Hypertension - A Patient's Survival Guide The premiere information
resource for people dealing with PH -- they have ARRIVED
and are ready to ship!!!
The author, a PH patient
herself, knows what it is like to live with the disease.
She talked to many other patients, doctors, and researchers
while writing the Survival Guide. Dr. Ronald J. Oudiz
and a team of physicians with a deep knowledge of
PH edited the book for accuracy.
New edition contains
a chart of 15 drugs used to treat
PH; results of recent clinical trials;
in-depth discussion of PH secondary to other
diseases or conditions; a new chapter on
what to eat if you have PH; and much,
much more!
Surface Logix Commences Phase IIa Trial for Novel PDE5 Inhibitor SLx-2101 in Patients with Endothelial Dysfunction
BOSTON, Nov.
30 /PRNewswire/ -- Surface Logix today announced the commencement
of a company-sponsored Phase IIa clinical trial for SLx-2101,
a new potent and selective long-acting, oral PDE5 inhibitor.
SLx-2101 is being evaluated for the treatment of vascular
and cardiovascular disease where endothelial dysfunction
is a significant component of the pathogenesis of the disease.
Resident with rare disease aims to educate, help others
THOMASTON - If you ever have the opportunity to meet or talk with Raye Bohn, you may never guess that she has a rare, incurable and life-threatening disease that forces her to be medicated 24 hours a day. Bohn, who turns 57 today, said she will not let something like Pulmonary Hypertension stop her from doing what she wants to do.
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.
